|Dosage & use||
Otrivin Comp should not be used for longer than 7 days as long-term treatment with decongestant preparations such as xylometaxolin (one of the active substances in Otrivin Comp) can cause swelling of the nasal mucosa (so-called rhinitis medicamentosa).
To reduce the risk of side effects, it is recommended that treatment with Otrivin Comp be stopped as soon as the symptoms subside, even if the treatment has not lasted the maximum 7 days.
There is only limited experience in the treatment of patients over 70 years of age.
The active substances are xylometazoline hydrochloride and ipratropium bromide. 1 ml contains 0.5 mg xylometazoline hydrochloride and 0.6 mg ipratroprium bromide. 1 spray dose contains 70 micrograms of xylometazoline hydrochloride and 84 micrograms of ipratroprium bromide.
Other ingredients are disodium edetate, glycerol (85%), purified water, as well as sodium hydroxide and hydrochloric acid.